Clinical Trials in the EU / 2026-527325-35-00
Ended
Phase I
Bioequivalence clinical trial of two formulations of empagliflozin/metformin
2026-527325-35-00 · tracked via the Priya Life Science EU tracker
Condition studied
Healthy volunteers
Eligibility
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View 2026-527325-35-00 on CTIS ↗ ← All trials in the EU